Research Reports | Market Assessment
October 2022

Biosimilars – Current Treatment – Nephrology

asdfasdf

Table of contents

  • Biosimilars - Current Treatment - Nephrology
    • Current Treatment Physician Insights Nephrology US/EU October 2022
Sunayna Joshi
Sunayna Joshi

Sunayna Joshi, B.Pharma., is an associate analyst on the Biosimilars team at Clarivate. Prior to joining the company, she worked as an associate at Prescient Health Care Group and as a knowledge management analyst at ZS Associates. She is experienced in pharmaceutical competitive analysis, clinical trial analysis, and market research. Ms. Joshi graduated from the Acropolis Institute of Technology in Indore, India, with a bachelor’s degree in pharmacy.

Hamzah Aideed, M.Sc.
Hamzah Aideed, M.Sc.

Hamzah Aideed, M.Sc., is a manager on the Biosimilars team at Clarivate. His team conducts both primary and secondary market research to provide in-depth analysis and key insights into biosimilars and the biopharmaceutical industry. Previously, Mr. Aideed was a senior research executive in consulting at McCann Health, specializing in the design and execution of advanced qualitative and quantitative research methodologies for bespoke ad-hoc consulting projects. He holds an M.Sc. in biotechnology, bioprocessing, and business management from the University of Warwick and a B.Sc. in biological chemistry from Aston University in Birmingham.

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports